TUBA4A may not be a significant genetic factor in Chinese ALS patients
Jiao Li(Beijing National Laboratory for Molecular Sciences), Dongsheng Fan(King University), Nan Zhang(Peking University), Lu Tang(Union Hospital), Yan Ma(Yunnan Agricultural University), Lianping Xu(Peking University), Ji He(Peking University), Lü Chen(Tianjin University of Traditional Chinese Medicine)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
October 14, 2015
Cited by 14
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing
|Genome Medicine|2019|537
Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis
|Journal of Neurology|2019|315